Have a personal or library account? Click to login
Collection of developmental history in the evaluation of schizophrenia spectrum disorders Cover

Collection of developmental history in the evaluation of schizophrenia spectrum disorders

Open Access
|Nov 2015

References

  1. Sorensen HJ, Mortensen EL, Schiffman J, Reinisch JM, Maeda J, Mednick SA. Early developmental milestones and risk of schizophrenia: a 45-year follow-up of the Copenhagen Perinatal Cohort. Schizophr Research 2010;118(1-3):41-47.
  2. Cannon M, Caspi A, Moffitt TE, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 2002;59(5):449-456.
  3. Isohanni M, Jones PB, Moilanen K, et al. Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 Birth Cohort. Schizophr Research 2001;52(1-2):1-19.
  4. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994;344(8934):1398-402.
  5. Fish B. Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry 1977;34(11):1297-313.
  6. Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am J Psychiatry 2004;161(11):2021-7.
  7. Rosso IM, Bearden CE, Hollister JM, et al. Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull 2000;26(2):367-378.
  8. Mittal VA, Neumann C, Saczawa M, Walker EF. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Arch Gen Psychiatry 2008;65(2):165-171.
  9. Mittal VA, Walker EF, Bearden CE, et al. Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period. Biol Psychiatry 2010;68(1):93-99.
  10. Schiffman J, Sorensen HJ, Maeda J, et al. Childhood motor coordination and adult schizophrenia spectrum disorders. Am J Psychiatry 2009;166(9):1041-7.
  11. Cannon M, Jones P, Huttunen MO, et al. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry 1999;56(5):457-463.
  12. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T. Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull 2000;26(2):379-393.
  13. Vorstman JA, Breetvelt EJ, Duijff SN, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry 2015;72(4):377-385.
  14. Bearden CE, Rosso IM, Hollister JM, Sanchez LE, Hadley T, Cannon TD. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr Bull 2000;26(2):395-410.
  15. Olin SC, Mednick SA, Cannon T, et al. School teacher ratings predictive of psychiatric outcome 25 years later. Br J Psychiatry Suppl 1998;172(33):7-13.
  16. Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry 2003;60(7):709-717.
  17. Olin SS, John RS, Mednick SA. Assessing the predictive value of teacher reports in a high risk sample for schizophrenia: a ROC analysis. Schizophr Res 1995;16(1):53-66.
  18. Eack SM, Greenwald DP, Hogarty SS, et al. Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study. J Autism Dev Disord 2013;43(12):2866-2877.
  19. Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS. Effects of cognitive enhancement therapy on employment outcomes in early schizophrenia: Results from a two-year randomized trial. Res Soc Work Pract 2011;21(1):32-42.
  20. Eack SM, Mesholam-Gately RI, Greenwald DP, Hogarty SS, Keshavan MS. Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy. Psychiatry Res 2013;209(1):21-26.
  21. Eack SM, Pogue-Geile MF, Greenwald DP, Hogarty SS, Keshavan MS. Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia. Psychol Med 2011;41(6):1253-1261.
  22. Revell ER, Neill JC, Harte M, Khan Z, Drake RJ. A systematic review and meta-analysis of cognitive remediation in early schizophrenia. Schizophr Res 2015;168(1-2):213-222.
  23. Ahn K, Gotay N, Andersen TM, et al. High rate of disease-related copy number variations in childhood onset schizophrenia. Molecular Psychiatry 2014;19(5):568-572.
  24. Addington AM, Rapoport JL. Annual research review: impact of advances in genetics in understanding developmental psychopathology. J Child Psychol Psychiatry 2012;53(5):510-8.
  25. Elia J, Gai X, Xie HM, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Molecular Psychiatry 2010;15(6):637-646.
  26. Malherbe PJ, Roos JL, Jr., Ehlers R, Karayiorgou M, Roos JL. Phenotypic features of patients with schizophrenia carrying de novo gene mutations: a pilot study. Psychiatry Res 2015;225(1-2):108-114.
  27. Szatkiewicz JP, O'Dushlaine C, Chen G, et al. Copy number variation in schizophrenia in Sweden. Molecular Psychiatry 2014;19(7):762-773.
  28. Vorstman JA, Breetvelt EJ, Thode KI, Chow EW, Bassett AS. Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion. Schizophr Res 2013;143(1):55-59.
  29. Cellini E, Vignoli A, Pisano T, et al. The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy. Dev Med Child Neurol 2016;58(1):93-97.
  30. Dale RC, Grattan-Smith P, Nicholson M, Peters GB. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study. Dev Med Child Neurol 2012;54(7):618-623.
  31. Peall KJ, Kurian MA, Wardle M, et al. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. J Neurol 2014;261(12):2296-304.
  32. McGrath LM, Yu D, Marshall C, et al. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J Am Acad Child Adolesc Psychiatry 2014;53(8):910-9.
  33. Tomiyasu A, Nakamura M, Ichiba M, et al. Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis. Am J Med Genet B Neuropsychiatr Genet 2011;156B(5):620-631.
  34. Delawalla Z, Barch DM, Fisher Eastep JL, et al. Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophr Bull 2006;32(3):525-537.
  35. Delawalla Z, Csernansky JG, Barch DM. Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biol Psychiatry 2008;63(5):490-7.
  36. Harms MP, Wang L, Mamah D, Barch DM, Thompson PA, Csernansky JG. Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J Neurosci 2007;27(50):13835-42.
  37. Harms MP, Wang L, Campanella C, et al. Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings. Br J Psychiatry 2010;196(2):150-7.
  38. Harms MP, Wang L, Csernansky JG, Barch DM. Structure-function relationship of working memory activity with hippocampal and prefrontal cortex volumes. Brain Struct Funct.2013;218(1):173-186.
  39. Barch DM, Cohen R, Csernansky J. Altered cognitive development in the siblings of individuals with schizophrenia. Clin Psychol Sci 2014;2(2):138-151.
  40. Cantor S. About normal children. In: Cantor S. Childhood Schizophrenia. New York: The Guilford Press; 1988. p. 57-74.
  41. Murphy KC. Annotation: velo-cardio-facial syndrome. J Child Psychol Psychiatry 2005;46(6):563-571.
  42. Hidding E, Swaab H, de Sonneville LM, et al. Intellectual functioning in relation to autism and ADHD symptomatology in children and adolescents with 22q11.2 deletion syndrome. J Intellect Disabil Res 2015;59(9):803-815.
  43. Schneider M, Debbane M, Bassett AS, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry 2014;171(6):627-639.
  44. Vorstman JA, Morcus ME, Duijff SN, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 2006;45(9):1104-1113.
  45. Arnedo J, Svrakic DM, Del Val C, et al. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am J Psychiatry 2015;172(2):139-153.
  46. Arnedo J, Mamah D, Baranger DA, et al. Decomposition of brain diffusion imaging data uncovers latent schizophrenias with distinct patterns of white matter anisotropy. NeuroImage 2015;120:43-54.
  47. Meier SM, Petersen L, Pedersen MG, et al. Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatry 2014;71(11):1215-1221.
Language: English
Page range: 36 - 43
Published on: Nov 30, 2015
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2015 Angela M. Reiersen, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.